MedyMatch looks to future of stroke detection with AI platform launch

Artificial intelligence healthcare startup MedyMatch Technology said late last month its AI platform designed to detect intracranial hemorrhage or brain bleeds is now available for research. The development is a milestone for the company, but is only the 1st stop for the platform, CEO Gene Saragnese told MassDevice.com in an interview. “What we’ve done at MedyMatch is develop not just an algorithm, but an AI platform which looks at the entire patient – that is to say, the full richness of 3D imaging plus other patient attributes – to allow us, firstly, to understand whether that person is hemorrhagic stroke,” Saragnese said. “Our 1st application is in the area of bleed detection. Then it is our intent to leverage this platform to attack the next level up in terms of challenges within stroke, which is things like occlusion assessment, trying to understand if it is not a hemorrhagic stroke and what and how should I treat this patient for an ischemic stroke.” The company focused on stroke 1st because of the massive risk it poses to the U.S. and the world as a whole, Saragnese said. By 2030, it is estimated that stroke will cost the US healthcare system $240 billion, and will affect 3.4 million people, he added. The platform is designed to help physicians make more informed decisions in stroke, which is important due to the challenges inherent in diagnosing stroke. “Stroke itself is sort of a distributed problem. People come into hospit...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Imaging Software / IT MedyMatch Source Type: news